Related Experiment Video
Updated: Jul 9, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus reactivation and multiple sclerosis
Ø Torkildsen1, H Nyland, H Myrmel
1Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway.
Abstract:
Infection with Epstein-Barr virus (EBV) is considered one of the possible key environmental factors in the aetiology of multiple sclerosis (MS). Whether EBV plays an underlying role as an activator of MS remains, however, controversial. Sixty-one patients with definite relapsing-remitting multiple sclerosis (RRMS) according to the Poser criteria were followed for 1 year. Blood samples were drawn at baseline, months 3, 6 and 12, and in case of any clinical exacerbation. Twenty-three baseline-paired exacerbation samples in the same set were quantitatively analysed to examine whether exacerbations in MS were associated with a change in anti-diffuse component of the EBV-early antigen (EA-D) IgG ratio. All the 61 patients (100%) were anti-viral capsid antigen (VCA) IgG positive, one (2%) was anti-VCA IgM positive and 60 (98%) were anti-EBV nuclear antigen IgG positive. Mean anti-EA-D IgG at baseline was 0.57 (range 0.12-2.70) and at the time of exacerbations 0.61 (range 0.11-2.70). Wilcoxon signed rank test revealed no differences between the 23 baseline and paired exacerbation samples (P = 0.58). Our findings suggest that reactivation of latent EBV infection does not play a significant role for exacerbations in RRMS.
Insights
Epstein-Barr virus (EBV) reactivation does not appear to trigger relapses in multiple sclerosis (MS). This study found no significant change in EBV-early antigen (EA-D) IgG ratios during MS exacerbations.
Area of Science:
- Neuroimmunology
- Virology
- Epidemiology
Background:
- Epstein-Barr virus (EBV) infection is a suspected environmental factor in multiple sclerosis (MS) etiology.
- The precise role of EBV in MS pathogenesis, particularly in disease exacerbations, remains debated.
Purpose of the Study:
- To investigate the association between EBV reactivation and clinical exacerbations in patients with relapsing-remitting multiple sclerosis (RRMS).
Main Methods:
- Quantitative analysis of anti-EBV-early antigen (EA-D) IgG ratios in blood samples from 61 RRMS patients.
- Samples were collected at baseline and during clinical exacerbations over a 1-year follow-up period.
- Comparison of antibody ratios between baseline and exacerbation samples using Wilcoxon signed rank test.
Main Results:
- All patients tested positive for anti-viral capsid antigen (VCA) IgG, indicating past EBV infection.
- No significant difference was observed in the mean anti-EA-D IgG ratio between baseline and exacerbation samples (P = 0.58).
- High prevalence of anti-EBV nuclear antigen IgG (98%) suggests latent EBV infection in the cohort.
Conclusions:
- Reactivation of latent Epstein-Barr virus infection is unlikely to be a significant trigger for exacerbations in relapsing-remitting multiple sclerosis.
- Further research may be needed to elucidate the complex relationship between EBV and MS.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cross-reactivity
Cytomegalovirus Disease
Arboviral Encephalitis